SPI
17 006,95
|
1,96
|
0,01 %
|
Analysen zu SPI-Werten
10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.25 | Zurich Insurance Overweight | Barclays Capital | |
10.04.25 | ABB Sell | Deutsche Bank AG | |
10.04.25 | UBS Buy | Deutsche Bank AG | |
10.04.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
10.04.25 | DocMorris Hold | Warburg Research | |
10.04.25 | Givaudan Add | Baader Bank | |
10.04.25 | DocMorris Add | Baader Bank | |
10.04.25 | DocMorris Buy | Jefferies & Company Inc. | |
10.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.25 | Novartis Neutral | UBS AG | |
10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
09.04.25 | Novartis Neutral | UBS AG | |
09.04.25 | UBS Hold | Jefferies & Company Inc. | |
09.04.25 | Richemont Hold | Deutsche Bank AG | |
08.04.25 | Richemont Overweight | JP Morgan Chase & Co. | |
08.04.25 | ams-OSRAM Buy | Deutsche Bank AG | |
08.04.25 | Richemont Buy | Jefferies & Company Inc. | |
08.04.25 | UBS Outperform | RBC Capital Markets | |
08.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
07.04.25 | Roche Buy | UBS AG | |
07.04.25 | Novartis Buy | Deutsche Bank AG | |
07.04.25 | Givaudan Add | Baader Bank | |
07.04.25 | Roche Sell | Deutsche Bank AG | |
07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
07.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
04.04.25 | Novartis Buy | Deutsche Bank AG | |
04.04.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
04.04.25 | ABB Sector Perform | RBC Capital Markets | |
04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
03.04.25 | DocMorris Buy | Jefferies & Company Inc. | |
03.04.25 | Roche Sell | Deutsche Bank AG | |
03.04.25 | Richemont Buy | UBS AG | |
03.04.25 | Novartis Buy | Deutsche Bank AG | |
03.04.25 | Novartis Outperform | Bernstein Research | |
03.04.25 | Roche Outperform | Bernstein Research | |
03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. |